As lower doses than recommended for weight loss have not been tested, we cannot answer this question yet
Weakness or Unsteadiness : Feeling weak, like your muscles cant support you, or being unable to stand or walk properly, indicates that fainting may follow
Lets compare the landmark phase studies for both molecules
You will then receive a personalized dosing protocol that starts at the standard initiation dose of 0.25 mg weekly and titrates gradually upward over approximately 16 to 20 weeks toward the therapeutic target dose of 2.4 mg weekly allowing your body time to adjust and minimizing the nausea and gastrointestinal side effects that occur when the dose is escalated too quickly
Mounjaro (Tirzepatide): Dual-Receptor Action Mounjaro works on both GLP-1 receptors (like Ozempic) and adds GIP receptors into the mix
therefore, while muscle mass goes down on scans, patients may be getting stronger, more mobile, and more physically capable